Primary adrenal insufficiency

Reading File
Reading File
Finding Sources
Searching PubMed

"primary adrenal insufficiency" AND "Addison disease"

Running Command
Finding Sources
Running Command
Reading File
Running Command
Reading File
Running Command
Reading File
Running Command
Reading File
Loading Image
Loading Image
I now have all the content needed. Here is a comprehensive summary of Primary Adrenal Insufficiency synthesized from Nelson Textbook of Pediatrics 2024 (Chapter 615) and Goldman-Cecil Medicine.

Primary Adrenal Insufficiency (Addison Disease)

Definition

Primary adrenal insufficiency (PAI) results from congenital or acquired destruction/dysfunction of the adrenal cortex itself, causing deficiency of cortisol and often aldosterone (and DHEA). This distinguishes it from secondary (pituitary ACTH deficiency) and tertiary (hypothalamic CRH deficiency) forms.
Normal HPA axis:
Normal HPA axis
In PAI, adrenal destruction → ↓cortisol → loss of negative feedback → ↑↑ CRH + ACTH → hyperpigmentation. Aldosterone deficiency → ↑ renin.
Primary adrenal insufficiency axis

Etiology

In Children — Genetic causes predominate (>65% of childhood PAI)

CategoryExamples
Inborn errors of steroidogenesis (CAH)21-hydroxylase def. (CYP21A2), 11β-hydroxylase def. (CYP11B1), 3β-HSD def., lipoid adrenal hyperplasia (StAR) — most common cause of PAI in infancy (~59%)
ACTH unresponsivenessFamilial glucocorticoid deficiency type 1 (MC2R), type 2 (MRAP); Triple A/Allgrove syndrome (AAAS)
Adrenal hypoplasia congenitaX-linked (NR0B1/DAX1) — common in males; NR5A1 (SF-1) deficiency
Peroxisomal defects / lipid metabolismX-linked adrenoleukodystrophy (ABCD1/Xq28) — most common in preadolescent boys; Zellweger syndrome, neonatal ALD
Mitochondrial / redox defectsNNT, TXNRD2 deficiency
Syndromic / growth restrictionIMAGe syndrome (CDKN1C), MIRAGE syndrome (SAMD9), Pallister-Hall (GLI3)

In Adults — Acquired causes predominate

CauseNotes
Autoimmune (Addison disease)~80% in developed countries; anti-CYP21A2 antibodies; isolated or as APS-1 (AIRE mutation: + hypoparathyroidism + mucocutaneous candidiasis) or APS-2 (+ autoimmune thyroid disease or T1DM)
InfectionsTB (historically), meningococcemia (Waterhouse-Friderichsen syndrome), histoplasmosis, cryptococcosis, CMV in AIDS
Infiltration / metastasesLung, breast, kidney, colon carcinoma; lymphoma; amyloidosis; hemochromatosis
Adrenal hemorrhageNeonatal (breech delivery); anticoagulated adults; antiphospholipid syndrome
DrugsKetoconazole, mitotane, etomidate, abiraterone, immune checkpoint inhibitors (nivolumab, pembrolizumab)
AdrenoleukodystrophyPresent in childhood/adolescence; ↑ plasma C26:0 very-long-chain fatty acids

Pathophysiology

DeficiencyConsequence
Cortisol ↓↓Cardiac output + vascular tone; catecholamine resistance → hypotension, shock; ↓gluconeogenesis → hypoglycemia; ↓free water excretion → hyponatremia; loss of negative feedback → ↑↑ACTH → hyperpigmentation
Aldosterone ↓↓Na⁺ reabsorption → hypovolemia, hyponatremia, salt craving; ↓K⁺ excretion → hyperkalemia
↑↑ ACTH / POMC peptidesSkin hyperpigmentation (via γ-MSH); prominent in creases, buccal mucosa, scars, nipples

Clinical Manifestations

Table: Signs, Symptoms, and Prevalence (Nelson 2024, Table 615.6)

FeatureMechanismPrevalence
Fatigue, anorexia, weight lossGC deficiency~90%
Nausea, vomitingGC + MC deficiency~90%
Hyperpigmentation (primary only)Excess ACTH/POMC~70%
Hypotension / orthostatic hypotensionMC + GC deficiency70–100%
HyponatremiaMC + GC deficiency~90%
Hyperkalemia (primary only)MC deficiency~50%
HypoglycemiaGC deficiency~30%
Salt craving (primary only)MC deficiency~20%
High ACTHGC deficiency100%
High plasma renin activityMC deficiency100%

Age-specific features:

  • Infants: Hyperkalemia, hyponatremia, hypoglycemia dominate; hyperpigmentation absent (takes weeks/months); decompensation can occur within days
  • Older children/adults: Insidious onset of weakness, malaise, weight loss, orthostatic hypotension; often misdiagnosed as chronic fatigue, depression, or anorexia nervosa; acute adrenal crisis can be precipitated by minor illness

Adrenal Crisis (acute):

Orthostatic hypotension → circulatory collapse, abdominal pain, fever, confusion. Most often caused by hemorrhage, metastasis, or acute infection. Life-threatening if untreated.

Diagnosis

Diagnostic algorithm (Nelson 2024, Fig. 615.2):
Primary Adrenal Insufficiency suspected
│
├─ Measure 17-OH-progesterone
│     (+) >1000 ng/dL → CAH (21-hydroxylase deficiency)
│     (−) ↓
│
├─ 21-OH Antibody (if >6 months)
│     (+) → Autoimmune AI (consider APS-1/APS-2)
│     (−) ↓
│
├─ VLCFA (males) → Adrenoleukodystrophy
│     (+) → ALD
│     (−) ↓
│
└─ CT Adrenals → Infiltrative disease, hemorrhage, infection, malignancy
   If negative → Genetic syndromes (rare CAH, AHC, etc.)

Key lab tests:

TestInterpretation
Morning serum cortisol<3 μg/dL diagnostic; >18 μg/dL excludes; 3–18 μg/dL indeterminate
ACTH stimulation test (gold standard)250 μg cosyntropin IV; cortisol <18 μg/dL at 30–60 min = PAI
Low-dose ACTH test1 μg/1.73 m² — more sensitive for secondary AI
Plasma ACTHHigh in primary; low/normal in secondary
Plasma renin activityElevated in primary (aldosterone deficiency)
ElectrolytesHyponatremia, hyperkalemia, hypoglycemia
Anti-CYP21A2 antibodiesAutoimmune Addison; small adrenals on imaging
VLCFAAdrenoleukodystrophy (screen all males with PAI)
CT/MRI adrenalsLarge +/− calcified (TB, fungal, hemorrhage); small (autoimmune)

Treatment

Acute Adrenal Crisis

  1. Draw blood for cortisol, ACTH, aldosterone, renin, electrolytes, glucose before treatment if possible
  2. IV fluids: 5% dextrose in 0.9% NaCl — corrects hypoglycemia, hypovolemia, hyponatremia. Avoid hypotonic fluids.
  3. Hydrocortisone sodium succinate IV bolus, then q6h × 24 hours:
    • Infants: 10 mg bolus
    • Toddlers: 25 mg
    • Older children: 50 mg
    • Adolescents: 100 mg
  4. Treat hyperkalemia if severe: IV calcium, bicarbonate, glucose/insulin, Kayexalate

Chronic Replacement

DrugDoseNotes
Hydrocortisone (glucocorticoid)10–15 mg/m²/day PO ÷ 3 dosesMonitor with ACTH levels (morning ACTH 1–4× ULN acceptable)
Fludrocortisone (mineralocorticoid)0.05–0.2 mg/day POMonitor with plasma renin activity; if primary AI only
DHEAAdults: controversialMay improve fatigue/energy, especially in women

Stress dosing:

  • Minor illness / fever: 2–3× usual hydrocortisone dose
  • Major surgery / GA: High-dose IV hydrocortisone (as for acute crisis)
⚠️ Caution: If concurrent hypothyroidism, treat adrenal insufficiency first — thyroxine accelerates cortisol clearance and can precipitate crisis if GC replacement is inadequate.
⚠️ Rifampicin, phenytoin, and phenobarbital induce hepatic steroid metabolism and reduce effectiveness of corticosteroid replacement — higher doses may be needed.

Key Distinguishing Features: Primary vs. Secondary AI

FeaturePrimarySecondary
CauseAdrenal gland destructionPituitary/hypothalamic ACTH or CRH ↓
Cortisol
AldosteroneNormal
ACTH↑↑↓ or inappropriately normal
HyperpigmentationYesNo
HyperkalemiaYesNo
HyponatremiaYesYes (mild)
Adrenal size on imagingSmall (autoimmune) or large (infiltration)Normal or small

Recent Evidence

Two 2024–2025 meta-analyses are notable:
  • Increased pregnancy/fetal complications in PAI (PMID: 39277840) — systematic review confirming adverse obstetric outcomes; relevant for management in women of reproductive age.
  • Increased mortality in PAI (PMID: 40966723) — 2025 meta-analysis confirming excess mortality, reinforcing the need for adequate replacement and sick-day rules.

Sources: Nelson Textbook of Pediatrics 2024, Chapter 615 (Perrin C. White); Goldman-Cecil Medicine, Chapter 208; provided Part 24 PDF attachment.

From Nelson only

Your credits are exhausted. Your daily credits reset tomorrow, or you can purchase a top-up for more.
This is a shared conversation. Sign in to Orris to start your own chat.